SCHEMBL5472388

SCHEMBL5472388

O=C1Nc2ccccc2/C1=C(\Cc1cnc(Cl)s1)c1c[nH]c2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCKBR P32239 5/20 0.39
▸ CCKAR P32238 2/20 0.39
▸ NTRK1 P04629 2/20 0.39
▸ DAPK3 O43293 1/20 0.39
▸ PRKD3 O94806 1/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ ABL1 P00519 1/20 0.39
▸ LCK P06239 1/20 0.39
▸ FYN P06241 1/20 0.39
▸ CSF1R P07333 1/20 0.39
▸ RET P07949 1/20 0.39
▸ PDGFRB P09619 1/20 0.39
▸ PDGFRA P16234 1/20 0.39
▸ LTK P29376 1/20 0.39
▸ GRK5 P34947 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ FLT3 P36888 1/20 0.39
▸ MAPK8 P45983 1/20 0.39
▸ CSNK1A1 P48729 1/20 0.39
▸ CDK7 P50613 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5472389 1.00 CCKBR (0.39) CCKBRCCKARNTRK1DAPK3PRKD3
SCHEMBL5822163 0.77 NTRK1 (0.48) CCKBRCCKARNTRK1DAPK3PRKD3
SCHEMBL5468659 0.76 NTRK1 (0.47) CCKBRCCKARNTRK1DAPK3PRKD3
SCHEMBL5469781 0.72 PBRM1 (0.51) CCKBRCCKARNTRK1DAPK3PRKD3
SCHEMBL5822242 0.69 ALDH1A1 (0.53) CCKBRCCKARLRRK2MEN1RAB9A
SCHEMBL5813081 0.68 NTRK1 (0.48) CCKBRCCKARNTRK1DAPK3PRKD3
SCHEMBL5822194 0.66 KMT2A (0.46) CCKBRCCKARMEN1KMT2ALMNA
SCHEMBL8688581 0.62 GABRP (0.50) GPR84HAT1EP300MEN1KMT2A
SCHEMBL30681308 0.62 IDO1 (0.57) PDGFRALTKLRRK2MEN1RAB9A
SCHEMBL7304930 0.62 IDO1 (0.57) PDGFRALTKLRRK2MEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070167488-A1 Novel therapeutic use LEO PHARMA A/S (DK) 2007-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167488-A1 Novel therapeutic use MAG, PMP22, MYT1 CCKBR 1771/4885CCKAR 2707/4885NTRK1 175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback